Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Sarcoma × surufatinib × Clear all

Phase

Status

Unknown 1 Terminated 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Biliary Tract Neoplasms 3 Small Cell Lung Carcinoma 2 Pancreatic Neoplasms 2 Carcinoma, Neuroendocrine 2 Carcinoma, Hepatocellular 2 Advanced Colorectal Cancer 2 Triple Negative Breast Neoplasms 1 Thyroid Neoplasms 1 Solid Tumor 1 Sarcoma 1 Refractory Metastatic Digestive System Carcinoma 1 Neuroendocrine Tumor Grade 3 1 Head and Neck Cancers - Salivary Gland 1 Gallbladder Neoplasms 1 Colorectal Neoplasms 1 Cholangiocarcinoma 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma 1 Breast Neoplasms 1 Advanced Non-Small Cell Lung Cancer 1

Interventions

Doxorubicin 14 Radiotherapy 9 Ifosfamide 9 apatinib 8 Cyclophosphamide 8 anlotinib 7 Vincristine 5 Dactinomycin 5 camrelizumab 4 toripalimab 3 Trabectedin 3 Radiation Dose Hypofractionation 3 Etoposide 3 Docetaxel 3 brostallicin 2 Topotecan 2 Temozolomide 2 Sorafenib 2 Oncolytic Virotherapy 2 Nivolumab 2 Melphalan 2 Magnetic Resonance Spectroscopy 2 Irinotecan 2 Ipilimumab 2 Gene Expression Profiling 2 Gemcitabine 2 Drug Therapy 2 Busulfan 2 Amplified Fragment Length Polymorphism Analysis 2 trofosfamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05106777 2023-04-12

Surufatinib in Patients With Osteosarcoma and Soft Tissue Sarcoma

Sun Yat-sen University

Phase 2 Unknown

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡